Abstract
Introduction
Dengue virus (DEN), a member of the Flaviviridae family, is primarily transmitted by Aedes aegypti and Aedes albopictus mosquitoes (1) . Dengue infection remains one of the most serious public health threats in developing countries in tropical or sub-tropical areas (1) . Approximately 50 million people are annually infected with DEN (2) . An estimated 2.5% of patients with severe manifestations affected die (3) . To date, no vaccines or specific anti-viral therapies are available. One of the obstacles to develop vaccines or specific anti-viral therapies to prevent dengue infection is that the mechanisms underlying the immunopathogenesis in dengue infection are still poorly understood. There are four major DEN serotypes, dengue virus serotype 1 (DEN-1), dengue virus serotype 2 (DEN-2), dengue virus serotype 3 (DEN-3) and dengue virus serotype 4 (DEN-4) (1). Data from epidemiological studies showed that secondary infection with a heterologous serotype of DEN might lead to dengue hemorrhagic fever (DHF) with plasma leakage, thrombocytopenia and occasionally hypovolemic shock. It was also widely believed that preexisting non-neutralizing antibodies might be able to form immunocomplexes with the DEN and therefore result in an enhanced infection of Fcc receptor-bearing cells like macrophages (i.e. antibodydependent enhancement) (4, 5) . However, it remains elusive how these could lead to DHF with plasma leakage and thrombocytopenia. It is, therefore, very important to determine how host immune responses can be involved in immunopathogenesis or anti-dengue immunity during dengue infection.
Though dengue-specific CD8
+ T cells might play a protective role in dengue infection (6) , activated CD8 + T cells together with specific cellular factors produced by these activated CD8
+ T cells were thought to be responsible for provoking immunopathogenesis of dengue infection (7, 8) . However, the dramatical variations in epitope presentation lead to extremely diverse spectrum of immune outcomes characterized by dynamic changes of their exact or relative numbers and diversity in the activation profiles, effector functions, phenotypes and molecular signatures of activated CD8 + T cells in response to stimulation by specific epitope peptides. To gain more insights into the immunopathogenesis and anti-dengue immunity mediated by CD8 + T cells in dengue infection, it is important to characterize the effector function, activation profiles and phenotypes of activated CD8
+ T cells reactive to certain immunodominant epitopes. We and others have recently screened several immunodominant DEN epitopes that could induce strong dengue-specific CD8 + T-cell, CD4
+ T-cell or B-cell immune responses (9) (10) (11) (12) (13) (14) . However, it is unknown whether DEN proteins harbor more immunodominant epitopes conserved in four major serotypes that could drive production of effector molecules by CD8
+ T cells and induce expression of certain phenotypes and activation profiles of CD8 + T cells that might lead to DHF. Recent strategies of assessing the immune responses of dengue-specific CD8 + T cells focused on the increased numbers of activated CD8 + T cells, especially the increased numbers of cross-reactive memory CD8 + T cells, which can produce pro-inflammatory cytokines such as tumor necrosis factor (TNF)-a and IFN-c. These pro-inflammatory cytokines may cause damage or dysfunction of endothelia cells, which finally leads to plasma leakage (6, 7, (15) (16) (17) . Briefly, the higher amounts of pro-inflammatory cytokines produced by activated CD8
+ T cells or cross-reactive memory CD8 + T cells, the severer the response leading to DHF is considered (18) . However, accumulating evidence suggested that CTL could clear virally infected target cells primarily via the exocytosis of cytotoxic granules containing granzymes and perforin (19) (20) (21) (22) (23) . It is unknown whether perforin could be up-regulated in CD8 + T cells activated by certain DEN epitope peptides. By now, no CD8 + T-cell reactive epitope that may drive the production of perforin has been defined. Furthermore, production of TNF-a and IFN-c by epitope peptide-stimulated CD8 + T cells are mostly analyzed by traditional intracellular cytokine staining (ICS) protocol using in vitro peptide re-stimulation, which may not reveal the true immunogenic nature of DEN epitope. Therefore, it remains unclear whether the production of large amounts of proinflammatory molecules such as TNF-a and IFN-c that may lead to DHF is an intrinsic property of CD8 + T cells reactive to certain DEN epitope peptides or just an artificial immune activation induced by in vitro peptide re-stimulation. Thus, analyzing whether DEN harbor some epitopes that can induce the de novo synthesis of TNF-a and IFN-c that do not require in vitro epitope peptide re-stimulation may provide new insights into how DEN-specific CD8 + T cells mediate the immunopathogenesis or anti-DEN immunity during dengue infection.
In this study, we screened several DEN CD8 + T-cell epitopes in the context of HLA-A*0201 molecule, which is one of the predominant human leukocyte antigen molecule (24) , through computational algorithms and flow cytometry. We then determined the immunogenicity of these DEN epitope peptides in HLA-A*0201 transgenic (Tg) mice. We demonstrated that immunization with epitope peptides that have strong binding affinity with HLA-A*0201 molecule could induce de novo production of large amounts of TNF-a, IFN-c and perforin in vivo by CD8 + T cells that preferentially displayed CD27
+

CD45RA
À but not CD27 À CD45RA + phenotypes.
Methods
Virus strains for bioinformatics analysis
Four different DEN strains that represented four major DEN serotypes, respectively, were selected for bioinformatics analysis-based prediction of HLA-A*0201-restricted CD8 + T-cell epitope. GZ01/1995 (DEN-1, GenBank accession no. ABK54370) and ZS01/2001 (DEN-2, GenBank accession no. ABK51383) were previously isolated and sequenced by us. Philippines/H87/1956 (DEN-3, GenBank accession no. P27915) and Philippines/H241/1956 (DEN-4, GenBank accession no. Q58HT7) are prototype DEN strains (25) .
Bioinformatics analysis
The amino acid sequences of non-structural 1 (NS1) and E proteins of four selected virus strains as mentioned above were used to predict HLA-A*0201-restricted CD8 + T-cell epitopes. By the use of the T-cell epitope prediction tools provided by the IEDB (26) and RANKPEP (27) (28) (29) with two different computational algorithms, we screened HLA-A*0201-restricted epitopes and selected consensus epitopes over two prediction results. Furthermore, cross-conservation analysis of epitopes was performed in the Epitope Conservancy Analysis of IEDB. Those epitopes conserved in at least two DEN serotypes were selected (see Table 1 ).
Peptides and antibodies
Peptides corresponding to defined HLA-A*0201-restricted CD8 + T-cell epitopes were synthesized by fluorenylmethyloxycarbonyl chemistry. Anti-mouse CD3 antibody and anti-mouse CD28 antibody were purchased from BD Pharmingen (San Diego, CA, USA). All antibodies conjugated with fluorescence stain for CD8 (PerCP-CY7), CD4 (PerCP-CY7), CD69 (PE), CD27 [allophycocyanin (APC)], CD45RA (FITC), IFN-c (FITC), perforin (PE), TNF-a (APC) and their isotype controls were purchased from eBioscience Corporation (San Diego, CA, USA).
Mice and immunization of mice with peptides
HLA-A*0201 (HLA-A2.1/Kb) Tg mice (30) were purchased from Shanghai Public Health Clinical Center (Shanghai, China). The usage of mice in this work was approved by Medical Ethical Committee of Zhongshan School of Medicine, Sun Yat-sen University. Mice were bred and maintained in specific pathogen-free facilities in Center for Laboratory Animals in SYSU. For experimental purposes, female mice were used at 6-8 weeks of age. The mice were injected at the base of the tail with 100 lg of the epitope of interest plus 120 lg of an I-A b -binding synthetic T-helper peptide from 208 Two new CD8 + T-cell epitopes on dengue NS1 protein hepatitis B virus (TPPAYRPPNAPIL). Peptides were emulsified in incomplete Freund's adjuvant at a ratio of 1:1. At day 7 after one-round immunization, half of the mice were sacrificed and the splenocytes were aseptically harvested to assess CTL responses. Another half of the mice were immunized and reimmunized again on days 7 and 14 after first-round immunization. Twenty-eight days since the first-round immunization, the splenocytes and bone marrow-derived dendritic cells (DCs) of the rest of the mice were isolated for further studies. Bone marrow-derived DCs were generated using a previously described method with some minor modifications (31) . Briefly, the femur bones was placed in serum-free RPMI 1640 medium (Gibco/Invitrogen, Beijing, China) with 100 IU ml À1 penicillin and 100 lg ml À1 streptomycin. The marrow was collected and gently re-suspended to make a single cell suspension. The RBCs in the cell suspension were deleted by using red blood cell lysing buffer (Sigma, St Louis, MO, USA). Then, the cells were washed in serum-free RPMI 1640 medium. The pellet was re-suspended in DC medium containing RPMI 1640 with L-glutamine, 25 mM HEPES, 10% heatactivated fetal bovine serum (FBS; HyClone Laboratories, Inc., Victoria, Australia), 100 IU ml À1 penicillin, 100 lg ml À1 streptomycin, 50 ng ml À1 mGM-CSF and mIL-4 (Peprotech, Rocky Hill, NJ, USA) and incubated at 37°C with 5% CO 2 . Non-adherent and loosely adherent cells were removed on day 3 and the remaining cells were cultured in fresh DC medium. On the basis of literature (32), we added 0.1 lg ml À1 LPS (Sigma) in the cell cultures to generate mature DCs on day 5. Mature DCs were harvested and washed on day 7.
T2 cells
Human transporter associated with antigen processingdeficient T2 cell line was a gift from Dr Haiquan Hu from The Third Military Medical University, Chongqing, China. Cell surface HLA-A*0201 expression was assessed by flow cytometry using anti-HLA-A2-FITC mAb (clone BB7.2; BD Pharmingen).
Fluorescence index-based determination of affinity peptide and HLA-A*0201 molecules on T2 cells
To determine whether synthetic peptides could bind to HLA-A*0201 molecules, peptide-induced HLA-A*0201 upregulation on T2 cells was examined according to a protocol described previously (33, 34) . Briefly, T2 cells were incubated with 50 lM candidate peptides and 3 lg ml À1 human b2-microglobulin (Sigma) in DMEM (Gibco/Invitrogen) medium for 18 h at 37°C in the presence of 5% CO 2 atmosphere. Expression of HLA-A*0201 on T2 cells was then determined by staining with FITC-conjugated (BB7.2) and cells were then analyzed using a FACSCalibur flow cytometer (BD Biosciences, Mountain View, CA, USA) and FlowJo software (Tree Star Inc., San Carlos, OR, USA). The fluorescence index (FI) was calculated as follows: FI = (mean FITC fluorescence with the given peptide À mean FITC fluorescence without peptide)/(mean FITC fluorescence without peptide). Peptides with FI >1 were considered as high-affinity epitope peptides. The HLA-A*0201-restricted influenza A virus matrix protein M1-derived peptide (GILGFVFTL) was used as a positive control (35) . The HLA-A*0201 non-binding peptide (IAGNSAYEY) derived from human cytomegalovirus glycoprotein B (HCMV GB) was used as a negative control (36) .
Confocal microscopic imaging
T2 cells stimulated with peptides or saline were stained with FITC-conjugated anti-HLA-A2 mAb (BB7.2) or isotype control antibody. Cells were then fixed with 2% formalin/PBS and mounted with medium with 4#,6-diamidino-2-phenylindole (Sigma) on slides, followed by imaging under a confocal scanning microscope (LSM 710; Carl Zeiss, Inc., Thornwood, NY, USA). All the imaging was done using the same confocal microscopic scanning parameters.
Cell surface and intracellular cytokine staining
Freshly purified lymphocytes isolated from the spleens that were derived from the naive mice or mice immunized with peptide or treated with saline were fixed first with 2% formalin/PBS. Cells were then washed thoroughly with 2% FBS/ PBS cell surface antigen markers such as CD3, CD8, CD4, CD27, CD45RA, CD69 or isotype control antibodies. Cells were then permeabilized with perm/fix reagents (BD Pharmingen) for 20 min and stained directly with mAbs against cytokines or perforin molecule. Cells were then washed again through using 2% FBS/PBS followed by the fixation again using 2% formalin/PBS. Cells were then subject to Flow cytometric analysis.
In vitro generation of peptide-specific CTLs in HLA-A*0201 Tg mice Mature DCs from bone marrow of immunized Tg mice were treated with mitomycin C (Sigma) at a final concentration of 25 lg ml À1 to avoid cell proliferation and pulsed with 20 lM of the candidate peptides in the presence of 3 lg ml À1 b-microglobulin for 3 h at 37°C with 5% CO 2 (35) . Splenocytes were co-cultured with peptide-pulsed mature DCs at a ratio of Estimated half-time of dissociation from the HLA-A*0201 allele using the web server IEDB and RANKPEP.
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10:1 at 37°C with 5% CO 2 in the presence of 20 U/ml mIL-2 (Gibco/Invitrogen, Camarillo, CA, USA). On day 6, induced cells were harvested and tested by cytotoxic assay.
Lactate dehydrogenase-based cytotoxic assay
Cytotoxic activity of the in vitro-stimulated CTLs was tested against peptides-pulsed T2 cells in a 4-h standard lactate dehydrogenase (LDH) release assay (CytoTox 96 Non-radioactive Cytotoxicity Assay; Promega, Madison, WI, USA) (37) . LDH release was measured in an enzymatic assay according to the manufacturer's instructions. Briefly, T2 cells were loaded with 20 lM candidate epitope peptides at 37°C with 5% CO 2 for 1 h. In vitro-stimulated CTLs used as effector cells were incubated with peptide-pulsed T2 cells that were used as target cells at an effector:target cell ratio of 10:1, 20:1 and 40:1, respectively (tested in duplicate). After incubation at 37°C with 5% CO 2 , 50 ll supernatants was collected from each well and mixed with the substrate mix provided in the kit. The reaction was stopped after 30 min and read at 490 nm absorbance. Specific cytotoxicity was calculated as: % Cytotoxicity = (experimental release À effector spontaneous release À target spontaneous release)/(target maximum release À target spontaneous release) 3 100.
Statistics
Student's t-tests were performed to determine the statistical differences as indicated in the result section. P <0.05 were considered significant.
Results
Computational algorithms-based prediction and in vitro binding of potential DEN CD8 + T-cell epitope peptides to HLA-A*0201 molecule
Since the HLA-A*0201 allele, a prototypic member of the HLA-A2 supertype family, is predominant in the human population (24) , especially in the dengue epidemic areas such as southeast Asia (38) , and the expression of HLA-A*0201 allele may be associated with the higher frequency of DHF upon secondary DEN infection (39, 40) , we have sought to search the deduced DEN amino acid sequence that are conserved in at least two major DEN serotypes for potential HLA-A*0201-binding regions using computational algorithms. Based on the computed binding scores to HLA-A*0201 molecule, seven peptide epitopes (Table 1) harbored on DEN NS1 or E protein with the highest predicted binding affinity to HLA-A*0201 molecules were selected from the potential epitope candidates that were predicted by computational algorithms (Supplementary  Table S1 is available at International Immunology Online). Seven DEN epitope peptides with the highest probability were synthesized and screened for binding affinity to HLA-A*0201 molecules in class I HLA-transfected BXT hybrid cell lines (T2 lines). The ability of these seven selected epitope peptides to bind to HLA molecule was assessed by measuring the binding affinity by FACS, expressed as FI. Two of the seven predicted epitope peptides were shown strong binding affinity (FI > 1) (Fig. 1A) . In contrast, the remaining five peptides showed FI of HLA-A*0201 molecules detectable by FACS on the surface of T2 cells lower than one (Fig. 1A) . In consistent, confocal microscope images also indicated that DEN-4 NS1 990-998 or DEN-4 NS1 997-1005 epitope peptide could specifically induce significant expression of HLA-A*0201 molecules on T2 cell surface (Fig. 1B) (Fig. 2B ). In contrast, only very low or background levels of CD69 expression were observed in CD8 + T cells that were isolated from the HLA-A*0201 Tg mice immunized with DEN-2 E 486-494 peptide or treated with saline (Fig. 2B) (Fig. 3A-D) . In contrast, very few IFN-c + CD8 + T cells and TNF-a + CD8 + T cells were observed in lymphocytes isolated from the spleens of mice immunized with DEN-2 E 486-494 peptide or treated with saline ( Fig. 3A-D 
CD8
+ T cells are thought to kill cells infected by virus or other pathogens predominantly through the release of cytolytic proteins such as perforin, granzyme and granulysin following recognition of infected monocytes or macrophages (42, 43) . However, by now, to our knowledge, no data are available to show whether and how CTLs specific for a single DEN epitope could produce perforin upon stimulation by epitope peptides. To determine whether DEN NS1 candidate epitope-specific CD8 + T cells display any cytolytic activity, fresh isolated spleen lymphocytes that were derived from epitope peptide-immunized HLA-A*0201 Tg mice were stained directly without in vitro peptide or anti-CD3/anti-CD28 re-stimulation. Interestingly, appreciated numbers of perforin + CD8 + T cells were observed in lymphocytes from the DEN-4 NS1 990-998 or DEN-4 NS1 997-1005 -immunized but not DEN-2 E 486-494 -immunized or saline-treated mice (Fig. 4A  and B) . Importantly, we found that percentages of perforin + CD8 + T cells were much higher than IFN-c + CD8
+ T cells and TNF-a + CD8 + T cells in isolated spleen lymphocytes that were derived from DEN-4 NS1 990-998 or DEN-4 NS1 997-1005 -immunized mice (Fig. 4C) , suggesting that some perforin-producing CD8 + T cells might also play an important role in immunopathogenesis and anti-dengue immunity and CTLs might be skewed toward cytolytic functions upon specific activation by certain immunodominant epitope peptides.
+ T cells specifically activated with DEN-4 NS1 990-998 or DEN-4 NS1 997-1005 epitope peptide preferentially displayed a CD27 + CD45RA À phenotype
It was previously shown that preferential expression of CD27 À CD45RA + phenotypes in CD8 + T cells was associated (Fig. 5A) . Indeed, compared with CD8 + T cells which received one-round stimulation with DEN NS1 candidate epitope peptide, the percentages of CD27
T cells over the total CD8
+ T cells increased upon threeround stimulations with DEN NS1 candidate epitope peptides (Fig. 5B) Fig. 6A and B) . These results therefore indicated that DEN-4 NS1 990-998 or DEN-4 NS1 997-1005 epitope-specific 
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+ T-cell epitopes on dengue NS1 protein 213 214 Two new CD8 + T-cell epitopes on dengue NS1 protein CD8 + T cells capable of producing large amounts of perforin, IFN-c and TNF-a was a correlate with strong cytolytic capability of DEN-specific CD8 + T cells, and such cytotoxicity mediated by CTLs was specific for DEN-4 NS1 990-998 or DEN-4 NS1 997-1005 epitope.
Discussion
It has been previously shown that levels of free DEN NS1 protein in human plasma correlated with viremia levels of DEN and were higher in patients with DHF than in those with dengue fever (DF) (47) Overproduction of pro-inflammatory cytokines such as IFN-c and TNF-a was thought to play critical roles in mediating immunopathogenesis of dengue infection (17) . independent experiments. (*P < 0.05, **P < 0.01, ***P < 0.001, NS, no statistical significance, N = 4).
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Unexpectedly, we found that DEN-4 NS1 990-998 and DEN-4 NS1 997-1005 epitope peptides capable of producing largescale activation of CD8 + T cell could induce de novo synthesis of IFN-c and TNF-a. Large amounts of IFN-c and TNF-a have been shown to be produced by activated CD8 + T cells receiving simulation with DEN epitope peptides from heterologous serotypes (7). However, IFN-c and TNF-a produced in vivo by T cells were usually detected with an ICS protocol with in vitro re-stimulation by peptide and antibodies such as anti-CD3, anti-CD28 and anti-CD49d (7). Importantly, these findings that a single DEN epitope peptide and a single immunization of the immunodominant epitope peptides could induce de novo synthesis of IFN-c and TNF-a might provide a new piece of evidence to explain why dengue infection could induce aberrant production of pro-inflammatory cytokines such as IFN-c and TNF-a that may lead to DHF.
Another important finding in this study was that single immunization with DEN-4 NS1 (17) , this finding should therefore provide another piece of information to help explain why DEN infection could induce DHF that is characterized by plasma leakage. While perforin played a critical role in lysing virally infected cells (42, 43, 46, (48) (49) (50) , the importance of perforin in dengue infection has not been fully appreciated. It has been previously described that perforin could be directly detected ex vivo after its production in vivo (51). However, to our knowledge, this is the first study showing that DEN epitope peptides could induce de novo production of perforin by dengue-specific CD8 + T cells. Our data also showed that de novo production of IFN-c, TNF-a and perforin by CD8 + T cells was associated with preferential sustained expression of CD27 + CD45RA À phenotypes but not CD27 À
CD45RA
+ or CD27 + CD45RA + phenotypes. This finding, however, is different from recent findings from others showing that a higher expression of cytolytic molecules was associated with CD27 À
+ , but not CD27 + CD45RA
À , phenotypes in murine or human CD8 + T cells (44, 46) . A simple straightforward explanation for the differences would be that the differentiation of the responding CD8 + T-cell population may reflect unique properties of the particular viral infection. However, an alternative, and possibly more important, explanation for this might be that differentiation of CD8 + T cells toward CD27 + CD45RA À phenotype was preferentially dictated by some immunodominant epitopes on DEN and preferential sustained expression CD27 + CD45RA À might play a significant role in immunopathogenesis or anti-DEN immunity during dengue infection. Actually, previous studies have shown that CD27 might be able to induce a co-stimulatory signal to promote activation and differentiation of T cells and increase the production of T-cell effector function (52) (53) (54) .
Finally, though the immunogenecity of DEN-4 NS1 990-998 and DEN-4 NS1 997-1005 epitope elucidated in this study merely rely on the synthetic peptides, it should be noted that the finding in this study demonstrating the importance of DEN-4 NS1 990-998 and DEN-4 NS1 997-1005 epitope harbored on NS1 protein in immunopathogenesis or anti-dengue immunity suggested that CD8 + T-cell response to DEN infection should be broader than what have been shown in previous studies (14, (55) (56) (57) which suggested that E, NS3, NS4A, NS4B or NS5 protein, especially NS3 (56), should harbor most of the immunodominant T-cell epitopes of DEN. Moreover, it would be critically important, in next-step work, to examine the role of DEN-4 NS1 990-998 and DEN-4 NS1 997-1005 epitope during in vivo dengue infection to further determine whether CD8 + T-cell specific for DEN-4 NS1 990-998 
